115 related articles for article (PubMed ID: 19880182)
1. Different susceptibilities to 1,25-dihydroxyvitamin D3-induced differentiation of AML cells carrying various mutations.
Gocek E; Kiełbiński M; Baurska H; Haus O; Kutner A; Marcinkowska E
Leuk Res; 2010 May; 34(5):649-57. PubMed ID: 19880182
[TBL] [Abstract][Full Text] [Related]
2. Side-chain modified vitamin D analogs induce rapid accumulation of VDR in the cell nuclei proportionately to their differentiation-inducing potential.
Gocek E; Kiełbiński M; Wyłób P; Kutner A; Marcinkowska E
Steroids; 2008 Dec; 73(14):1359-66. PubMed ID: 18644400
[TBL] [Abstract][Full Text] [Related]
3. Carnosic acid potentiates the antioxidant and prodifferentiation effects of 1alpha,25-dihydroxyvitamin D3 in leukemia cells but does not promote elevation of basal levels of intracellular calcium.
Danilenko M; Wang Q; Wang X; Levy J; Sharoni Y; Studzinski GP
Cancer Res; 2003 Mar; 63(6):1325-32. PubMed ID: 12649194
[TBL] [Abstract][Full Text] [Related]
4. Effect of 25-hydroxyl group orientation on biological activity and binding to the 1alpha,25-dihydroxy vitamin D3 receptor.
Collins ED; Bishop JE; Bula CM; Acevedo A; Okamura WH; Norman AW
J Steroid Biochem Mol Biol; 2005 Mar; 94(4):279-88. PubMed ID: 15857747
[TBL] [Abstract][Full Text] [Related]
5. Side-chain modified vitamin D analogs require activation of both PI 3-K and erk1,2 signal transduction pathways to induce differentiation of human promyelocytic leukemia cells.
Marcinkowska E; Kutner A
Acta Biochim Pol; 2002; 49(2):393-406. PubMed ID: 12362981
[TBL] [Abstract][Full Text] [Related]
6. Opposite regulation of vitamin D receptor by ATRA in AML cells susceptible and resistant to vitamin D-induced differentiation.
Gocek E; Marchwicka A; Baurska H; Chrobak A; Marcinkowska E
J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):220-6. PubMed ID: 22789609
[TBL] [Abstract][Full Text] [Related]
7. Dimethyl fumarate and vitamin D derivatives cooperatively enhance VDR and Nrf2 signaling in differentiating AML cells in vitro and inhibit leukemia progression in a xenograft mouse model.
Nachliely M; Trachtenberg A; Khalfin B; Nalbandyan K; Cohen-Lahav M; Yasuda K; Sakaki T; Kutner A; Danilenko M
J Steroid Biochem Mol Biol; 2019 Apr; 188():8-16. PubMed ID: 30508646
[TBL] [Abstract][Full Text] [Related]
8. Structure-function analysis of vitamin D(2) analogs as potential inducers of leukemia differentiation and inhibitors of prostate cancer proliferation.
Baurska H; Klopot A; Kielbinski M; Chrobak A; Wijas E; Kutner A; Marcinkowska E
J Steroid Biochem Mol Biol; 2011 Aug; 126(1-2):46-54. PubMed ID: 21550403
[TBL] [Abstract][Full Text] [Related]
9. Cellular zinc homeostasis is a regulator in monocyte differentiation of HL-60 cells by 1 alpha,25-dihydroxyvitamin D3.
Dubben S; Hönscheid A; Winkler K; Rink L; Haase H
J Leukoc Biol; 2010 May; 87(5):833-44. PubMed ID: 20089671
[TBL] [Abstract][Full Text] [Related]
10. Monocytic differentiation induced by side-chain modified analogs of vitamin D in ex vivo cells from patients with acute myeloid leukemia.
Baurska H; Kiełbiński M; Biecek P; Haus O; Jaźwiec B; Kutner A; Marcinkowska E
Leuk Res; 2014 May; 38(5):638-47. PubMed ID: 24703772
[TBL] [Abstract][Full Text] [Related]
11. Kinase suppressor of RAS (KSR) amplifies the differentiation signal provided by low concentrations 1,25-dihydroxyvitamin D3.
Wang X; Studzinski GP
J Cell Physiol; 2004 Mar; 198(3):333-42. PubMed ID: 14755538
[TBL] [Abstract][Full Text] [Related]
12. Novel analogs of 1,25-dihydroxyvitamin D
Nachliely M; Sharony E; Kutner A; Danilenko M
J Steroid Biochem Mol Biol; 2016 Nov; 164():59-65. PubMed ID: 26365556
[TBL] [Abstract][Full Text] [Related]
13. Cooperation between antioxidants and 1,25-dihydroxyvitamin D3 in induction of leukemia HL60 cell differentiation through the JNK/AP-1/Egr-1 pathway.
Wang Q; Salman H; Danilenko M; Studzinski GP
J Cell Physiol; 2005 Sep; 204(3):964-74. PubMed ID: 15799027
[TBL] [Abstract][Full Text] [Related]
14. Enhancing effects of ceramide derivatives on 1,25-dihydroxyvitamin D(3)-induced differentiation of human HL-60 leukemia cells.
Kim DS; Kim SH; Song JH; Chang YT; Hwang SY; Kim TS
Life Sci; 2007 Dec; 81(25-26):1638-44. PubMed ID: 18031762
[TBL] [Abstract][Full Text] [Related]
15. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
16. 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells.
Koeffler HP; Hirji K; Itri L
Cancer Treat Rep; 1985 Dec; 69(12):1399-407. PubMed ID: 2416438
[TBL] [Abstract][Full Text] [Related]
17. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
18. Heat shock protein 90 interacts with vitamin D receptor in human leukemia cells.
Marcinkowska E; Gocek E
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):114-6. PubMed ID: 20138989
[TBL] [Abstract][Full Text] [Related]
19. Evidence for tissue- and cell-type selective activation of the vitamin D receptor by Ro-26-9228, a noncalcemic analog of vitamin D3.
Peleg S; Ismail A; Uskokovic MR; Avnur Z
J Cell Biochem; 2003 Feb; 88(2):267-73. PubMed ID: 12520525
[TBL] [Abstract][Full Text] [Related]
20. Flt3-mediated signaling in human acute myelogenous leukemia (AML) blasts: a functional characterization of Flt3-ligand effects in AML cell populations with and without genetic Flt3 abnormalities.
Bruserud Ø; Hovland R; Wergeland L; Huang TS; Gjertsen BT
Haematologica; 2003 Apr; 88(4):416-28. PubMed ID: 12681969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
